Skip to main content

Table 1 Demographic features of a total of 92 patients with UC

From: Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis

Characteristics

N=92

Age(year), mean(range)±SD

48.5 (14-83) ±16.3

Male/Female, n(%)

64/28 (69.6/30.4)

Disease duration(year), mean(range)±SD

7.2 (0.1-26) ± 7.1

Disease extent, n(%)

 Extensive colitis

57 (63.0)

 Left sided colitis

24 (26.1)

 Proctitis

11 (10.9)

CAI(Lichtiger socre) mean(range)±SD

3.4 ± 4.3

eMayo mean(range)±SD

1.0 (0-3) ±1.0

 eMayo 0, n (%)

38 (41.3)

 eMayo 1, n (%)

21 (22.8)

 eMayo 2, n (%)

27 (29.3)

 eMayo 3, n (%)

6 (6.6)

UCEIS mean(range)±SD

2.1 (0-7) ± 1.9

PGE-MUM (μ·g-1·Cr-1) mean(range)±SD

29.2 (5.1-93.9) ± 18.5

Fecal hemoglobin concentrations (ng/ml), n (%) mean(range)±SD

2178 (0-26500) ± 4667

Drug at study, n (%)

 Oral 5-ASA

58 (63.0)

 Suppository 5-ASA

12 (13.0)

 Systemic steroids

12 (13.0)

 Azathioprine / Mercaptopurine

35 (38.0)

 Tacrolimus

10 (10.9)

 Biologics

25 (27.2)

  1. CAI clinical activity index, eMayo Mayo endoscopic subscore, UCEIS Ulcerative Colitis Endoscopic Index of severity, PGE-MUM Prostaglandin E-Major Urinary Metabolite, 5-ASA 5-aminosalicylic acid